Contributors
HEM
NS-W, AT, SR, DNT, BS, OVM, SD, and WMK conceptualised the study. SR, AP, AT, WMK, and DNT supervised the study. SR, BS, NS-W, and AT developed the methods. VKBK was the principal investigator responsible for the general oversight of the study. MC (the national coordinator) was responsible for project supervision in Guinea. DNT followed by MIWK was the coordinating investigator in the Democratic Republic of the Congo responsible for project supervision in the Democratic Republic of the Congo and Guinea. HMM, JMM, MLC, FAM, LKB, AKB, PKL, SMK, PMP, RMN, HEM, AAAN, VKM, EMN, and AFNB (clinical trial investigators) oversaw the study sites under the supervision of EMM and MC. JC, SS, and MN were responsible for data collection and verification at sites in the Democratic Republic of the Congo. OVM, AT, AP, and SR were involved in data validation. SR and AP did the data visualisation. DNT, NS-W, AT, and SR were involved in supervision. BS did the formal analysis of complementary analyses. AP and SD oversaw resources. SR, NS-W, AT, and OVM were involved in funding acquisition. VKBK and AT have accessed and verified all the data in the study. All authors had full access to all the data in the study and accept responsibility for the decision to submit for publication. SR, OVM, BS, AP, and AT wrote the original draft. All authors reviewed and approved the final version.